查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1972874

主動式傷口護理市場：市場洞察、競爭格局與預測（2033年）

Active Wound Care Market Insights, Competitive Landscape, and Market Forecast - 2033
出版日期: | 出版商: Fairfield Market Research | 英文 196 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

全球主動式傷口護理市場預計將穩定成長，2026年達到 28億美元，2033年達到 38億美元，年複合成長率（CAGR）為 4.60%。該成長趨勢得益於慢性傷口盛行率的上升、對先進傷口癒合解決方案的需求不斷成長以及傷口護理技術的持續創新。

市場概覽

主動式傷口護理產品目的是透過生物活性機制促進急性和慢性傷口的癒合過程。這些產品包括皮膚替代物、生長因子和生物材料等療法，能夠支持組織再生、預防感染並加速癒合。市場正從傳統的傷口管理技術轉向能夠改善患者預後和生活品質的主動式傷口護理解決方案。

生物工程皮膚替代物和基於生長因子的療法的最新進展重新定義傷口護理。隨著患者意識的提高和醫療機構的廣泛應用，主動式傷口護理產品正成為現代傷口管理策略的重要組成部分。人們越來越重視縮短住院時間和減少併發症，這也推動了這些先進解決方案的普及。

市場驅動因素

推動主動式傷口護理市場成長的關鍵因素有很多。糖尿病、靜脈性腿部潰瘍和壓瘡等慢性疾病發生率的上升，使得對先進傷口護理產品的需求顯著增加。此外，老年人口的成長（老年人更容易出現癒合延遲的傷口）也促進了市場的持續成長。

技術創新也是一個強大的驅動力，生物工程皮膚替代物、生長因子療法和生物材料與傳統傷口敷料相比，能夠實現更快、更有效的癒合。家庭醫療保健和以患者為中心的護理模式的興起，也為用戶友善型先進傷口護理解決方案提供了更多機會。

醫療基礎設施的改善，尤其是在新興地區，支持市場擴張。政府和私人醫療機構對傷口護理計畫的投資目的是減輕慢性傷口帶來的臨床和經濟負擔。一些已開發國家擴大先進傷口護理療法的償付支持，也加速了市場對此療法的接受度。

市場參與者的機會

傷口護理市場為製造商、投資者和醫療機構提供了多元化的機會。專注於創新療法的公司，例如生物工程皮膚替代物、生長因子製劑和生物材料，可以充分利用市場對有效且安全的傷口癒合解決方案日益成長的需求。

亞太地區、拉丁美洲以及中東和非洲等新興市場由於醫療成本上升、病患意識增強以及醫療基礎設施改善，蘊藏著巨大的成長潛力。包括遠端傷口監測和遠距醫療在內的數位醫療解決方案的整合，為產品開發和服務交付開闢新的途徑。

生技公司、研究機構和醫療機構之間的合作促進產品的快速商業化。策略性併購也為拓展產品組合、增強區域影響力以及擴大分銷網路提供了機會。

區域分析

北美仍然是主動傷口護理領域最大的市場，這主要得益於高額的醫療保健支出、完善的基礎設施以及慢性傷口患病率的上升。美國在該市場佔據領先地位，這得益於其研發投入和先進傷口護理產品的廣泛應用。

歐洲是一個成熟的市場，其特點是創新傷口治療方法的普及率很高。德國、英國和法國等國家擁有健全的醫療保健和償付體系，為市場成長做出了顯著貢獻。

亞太地區崛起為一個高成長地區，這主要得益於人們對先進傷口護理的認識不斷提高、患者群體不斷成長以及醫療保健投資的增加。中國、日本和印度是該地區市場擴張的重要貢獻者。

拉丁美洲以及中東和非洲的市場逐步擴張，這得益於醫療保健基礎設施的改善、人們意識的提高以及先進傷口護理解決方案的日益普及。

主要參與者

傷口護理市場的競爭格局包括專注於創新和策略擴張的成熟企業和新興企業。主要市場參與者包括：

  • Smith & Nephew
  • MiMedx
  • Tissue Regenix
  • Organogenesis Inc.
  • Acell Inc.
  • Integra Life Sciences
  • Solsys Medical
  • Osiris Therapeutics Inc.
  • Cytori Therapeutics Inc.
  • Human BioSciences
  • Wright Medical Group N.V.

這些公司優先考慮研發、聯盟和策略合作，以擴展其產品組合、推出先進療法並加強其區域影響力。

市場區隔

依產品分類：

  • 皮膚替代品
  • 生長因子
  • 生物材料

依自動化程度分類：

  • 慢性傷口
  • 急性傷口

依最終使用者分類：

  • 醫院
  • 家庭醫療保健
  • 專科診所
  • 其他

依地區：

  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

目錄

第1章 執行概要摘要

第2章 市場概覽

  • 市場定義與細分
  • 市場動態
    • 驅動因素
    • 限制因素
    • 市場機會
  • 價值鏈分析
  • 新冠疫情影響分析
  • 波特五力分析
  • 俄烏衝突的影響
  • PESTLE分析
  • 監理分析
  • 價格趨勢分析
    • 當前價格及未來預測（2025-2033年）
    • 價格影響因素

第3章 全球主動傷口照護市場預測（2020-2033年）

  • 全球主動傷口護理市場展望，依產品，價值（十億美元），2020-2033年
    • 皮膚替代品
    • 生長因子
    • 生物材料
  • 全球主動傷口護理市場預測，依自動化，價值（十億美元），2020-2033年
    • 慢性傷口
    • 急性傷口
  • 全球主動傷口護理市場預測，依最終用戶，價值（十億美元），2020-2033年
    • 醫院
    • 家庭醫療保健
    • 專科診所
    • 其他
  • 全球主動傷口護理市場預測，依地區，價值（十億美元），2020-2033年
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲美洲
    • 中東和非洲

第4章 北美主動傷口護理市場展望（2020-2033）

第5章 歐洲主動傷口護理市場展望（2020-2033）

第6章 亞太地區主動傷口照護市場展望（2020-2033）

第7章 拉丁美洲主動傷口護理市場展望（2020-2033）

第8章 中東與非洲主動傷口照護市場展望（2020-2033）

第9章 競爭格局

  • 公司與細分市場熱圖
  • 公司市場佔有率分析2025
  • 競爭格局概覽
  • 公司簡介
    • Smith & Nephew
    • MiMedx
    • Tissue Regenix
    • Organogenesis Inc.
    • Acell Inc.
    • Integra Life Sciences
    • Solsys Medical
    • Osiris Therapeutics Inc.
    • Cytori Therapeutics Inc.
    • Human BioSciences

第10章 附錄

簡介目錄

The global Active Wound Care Market is expected to experience steady growth, with market value projected at USD 2.8 billion in 2026 and anticipated to reach USD 3.8 billion by 2033, reflecting a compound annual growth rate (CAGR) of 4.60%. The growth trajectory is supported by the increasing prevalence of chronic wounds, rising demand for advanced wound healing solutions, and continuous innovations in wound care technologies.

Market Overview

Active wound care products are designed to accelerate the healing process for both acute and chronic wounds through biologically active mechanisms. This includes therapies such as skin substitutes, growth factors, and biomaterials that support tissue regeneration, prevent infections, and reduce healing time. The market is witnessing a shift from conventional wound management techniques to active wound care solutions that enhance patient outcomes and improve quality of life.

Recent advancements in bioengineered skin substitutes and growth factor-based treatments are redefining the wound care landscape. With rising patient awareness and increased adoption among healthcare providers, active wound care products are becoming integral to modern wound management strategies. The increasing emphasis on reducing hospital stays and minimizing complications is further driving the adoption of these advanced solutions.

Market Drivers

Several key factors are propelling the growth of the active wound care market. The rising incidence of chronic conditions such as diabetes, venous leg ulcers, and pressure injuries has created a significant demand for advanced wound care products. Additionally, the expanding geriatric population, more prone to slow-healing wounds, is contributing to sustained market growth.

Technological innovations remain a strong driver, with bioengineered skin substitutes, growth factor therapies, and biomaterials providing faster, more effective healing compared to traditional wound dressings. The rising trend of home healthcare and patient-centric care models is also expanding opportunities for easy-to-use, advanced wound care solutions.

Healthcare infrastructure improvements, particularly in emerging regions, are supporting market expansion. Investments by governments and private healthcare providers in wound care programs are aimed at lowering the clinical and economic burden associated with chronic wounds. Increased reimbursement support for advanced wound care therapies in several developed countries is another factor accelerating market adoption.

Opportunities for Market Players

The active wound care market presents diverse opportunities for manufacturers, investors, and healthcare providers. Companies focusing on innovative therapies, such as bioengineered skin substitutes, growth factor formulations, and biomaterials, can capitalize on the increasing demand for effective and safe wound healing solutions.

Emerging markets in Asia Pacific, Latin America, and the Middle East & Africa offer substantial growth potential due to rising healthcare expenditures, growing patient awareness, and improving medical infrastructure. Integration of digital healthcare solutions, including remote wound monitoring and telemedicine, is opening new avenues for product development and service delivery.

Collaborations between biotechnology firms, research institutions, and healthcare providers are fostering faster product commercialization. Strategic mergers and acquisitions also provide opportunities to expand product portfolios, enhance regional presence, and strengthen distribution networks.

Regional Analysis

North America remains the largest market for active wound care, driven by high healthcare spending, established infrastructure, and rising chronic wound prevalence. The United States leads the market, supported by research investments and widespread adoption of advanced wound care products.

Europe represents a mature market with high adoption rates for innovative wound therapies. Countries such as Germany, the UK, and France contribute significantly to market growth, supported by strong healthcare systems and reimbursement frameworks.

Asia Pacific is emerging as a high-growth region, fueled by increasing awareness of advanced wound care, growing patient populations, and rising healthcare investments. China, Japan, and India are notable contributors to market expansion in this region.

Latin America and Middle East & Africa are gradually expanding markets, supported by improving healthcare infrastructure, increased awareness, and rising adoption of advanced wound care solutions.

Key Players

The competitive landscape of the active wound care market includes established and emerging companies focused on innovation and strategic expansion. Prominent market players include:

  • Smith & Nephew
  • MiMedx
  • Tissue Regenix
  • Organogenesis Inc.
  • Acell Inc.
  • Integra Life Sciences
  • Solsys Medical
  • Osiris Therapeutics Inc.
  • Cytori Therapeutics Inc.
  • Human BioSciences
  • Wright Medical Group N.V.

These companies prioritize research and development, collaborations, and strategic partnerships to expand their product portfolios, introduce advanced therapies, and enhance regional reach.

Market Segmentation

By Product:

  • Skin Substitutes
  • Growth Factors
  • Biomaterials

By Automation:

  • Chronic Wounds
  • Acute Wounds

By End User:

  • Hospitals
  • Home Healthcare
  • Specialty Clinics
  • Others

By Geographic Coverage:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Active Wound Care Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Five Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Active Wound Care Market Outlook, 2020-2033

  • 3.1. Global Active Wound Care Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 3.1.1. Skin Substitutes
    • 3.1.2. Growth Factors
    • 3.1.3. Biomaterials
  • 3.2. Global Active Wound Care Market Outlook, by Automation, Value (US$ Bn), 2020-2033
    • 3.2.1. Chronic Wounds
    • 3.2.2. Acute Wounds
  • 3.3. Global Active Wound Care Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 3.3.1. Hospitals
    • 3.3.2. Home Healthcare
    • 3.3.3. Specialty Clinics
    • 3.3.4. Others
  • 3.4. Global Active Wound Care Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.4.1. North America
    • 3.4.2. Europe
    • 3.4.3. Asia Pacific
    • 3.4.4. Latin America
    • 3.4.5. Middle East & Africa

4. North America Active Wound Care Market Outlook, 2020-2033

  • 4.1. North America Active Wound Care Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 4.1.1. Skin Substitutes
    • 4.1.2. Growth Factors
    • 4.1.3. Biomaterials
  • 4.2. North America Active Wound Care Market Outlook, by Automation, Value (US$ Bn), 2020-2033
    • 4.2.1. Chronic Wounds
    • 4.2.2. Acute Wounds
  • 4.3. North America Active Wound Care Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 4.3.1. Hospitals
    • 4.3.2. Home Healthcare
    • 4.3.3. Specialty Clinics
    • 4.3.4. Others
  • 4.4. North America Active Wound Care Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.4.1. U.S. Active Wound Care Market Outlook, by Product, 2020-2033
    • 4.4.2. U.S. Active Wound Care Market Outlook, by Automation, 2020-2033
    • 4.4.3. U.S. Active Wound Care Market Outlook, by End User, 2020-2033
    • 4.4.4. Canada Active Wound Care Market Outlook, by Product, 2020-2033
    • 4.4.5. Canada Active Wound Care Market Outlook, by Automation, 2020-2033
    • 4.4.6. Canada Active Wound Care Market Outlook, by End User, 2020-2033
  • 4.5. BPS Analysis/Market Attractiveness Analysis

5. Europe Active Wound Care Market Outlook, 2020-2033

  • 5.1. Europe Active Wound Care Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 5.1.1. Skin Substitutes
    • 5.1.2. Growth Factors
    • 5.1.3. Biomaterials
  • 5.2. Europe Active Wound Care Market Outlook, by Automation, Value (US$ Bn), 2020-2033
    • 5.2.1. Chronic Wounds
    • 5.2.2. Acute Wounds
  • 5.3. Europe Active Wound Care Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 5.3.1. Hospitals
    • 5.3.2. Home Healthcare
    • 5.3.3. Specialty Clinics
    • 5.3.4. Others
  • 5.4. Europe Active Wound Care Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.4.1. Germany Active Wound Care Market Outlook, by Product, 2020-2033
    • 5.4.2. Germany Active Wound Care Market Outlook, by Automation, 2020-2033
    • 5.4.3. Germany Active Wound Care Market Outlook, by End User, 2020-2033
    • 5.4.4. Italy Active Wound Care Market Outlook, by Product, 2020-2033
    • 5.4.5. Italy Active Wound Care Market Outlook, by Automation, 2020-2033
    • 5.4.6. Italy Active Wound Care Market Outlook, by End User, 2020-2033
    • 5.4.7. France Active Wound Care Market Outlook, by Product, 2020-2033
    • 5.4.8. France Active Wound Care Market Outlook, by Automation, 2020-2033
    • 5.4.9. France Active Wound Care Market Outlook, by End User, 2020-2033
    • 5.4.10. U.K. Active Wound Care Market Outlook, by Product, 2020-2033
    • 5.4.11. U.K. Active Wound Care Market Outlook, by Automation, 2020-2033
    • 5.4.12. U.K. Active Wound Care Market Outlook, by End User, 2020-2033
    • 5.4.13. Spain Active Wound Care Market Outlook, by Product, 2020-2033
    • 5.4.14. Spain Active Wound Care Market Outlook, by Automation, 2020-2033
    • 5.4.15. Spain Active Wound Care Market Outlook, by End User, 2020-2033
    • 5.4.16. Russia Active Wound Care Market Outlook, by Product, 2020-2033
    • 5.4.17. Russia Active Wound Care Market Outlook, by Automation, 2020-2033
    • 5.4.18. Russia Active Wound Care Market Outlook, by End User, 2020-2033
    • 5.4.19. Rest of Europe Active Wound Care Market Outlook, by Product, 2020-2033
    • 5.4.20. Rest of Europe Active Wound Care Market Outlook, by Automation, 2020-2033
    • 5.4.21. Rest of Europe Active Wound Care Market Outlook, by End User, 2020-2033
  • 5.5. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Active Wound Care Market Outlook, 2020-2033

  • 6.1. Asia Pacific Active Wound Care Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 6.1.1. Skin Substitutes
    • 6.1.2. Growth Factors
    • 6.1.3. Biomaterials
  • 6.2. Asia Pacific Active Wound Care Market Outlook, by Automation, Value (US$ Bn), 2020-2033
    • 6.2.1. Chronic Wounds
    • 6.2.2. Acute Wounds
  • 6.3. Asia Pacific Active Wound Care Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 6.3.1. Hospitals
    • 6.3.2. Home Healthcare
    • 6.3.3. Specialty Clinics
    • 6.3.4. Others
  • 6.4. Asia Pacific Active Wound Care Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.4.1. China Active Wound Care Market Outlook, by Product, 2020-2033
    • 6.4.2. China Active Wound Care Market Outlook, by Automation, 2020-2033
    • 6.4.3. China Active Wound Care Market Outlook, by End User, 2020-2033
    • 6.4.4. Japan Active Wound Care Market Outlook, by Product, 2020-2033
    • 6.4.5. Japan Active Wound Care Market Outlook, by Automation, 2020-2033
    • 6.4.6. Japan Active Wound Care Market Outlook, by End User, 2020-2033
    • 6.4.7. South Korea Active Wound Care Market Outlook, by Product, 2020-2033
    • 6.4.8. South Korea Active Wound Care Market Outlook, by Automation, 2020-2033
    • 6.4.9. South Korea Active Wound Care Market Outlook, by End User, 2020-2033
    • 6.4.10. India Active Wound Care Market Outlook, by Product, 2020-2033
    • 6.4.11. India Active Wound Care Market Outlook, by Automation, 2020-2033
    • 6.4.12. India Active Wound Care Market Outlook, by End User, 2020-2033
    • 6.4.13. Southeast Asia Active Wound Care Market Outlook, by Product, 2020-2033
    • 6.4.14. Southeast Asia Active Wound Care Market Outlook, by Automation, 2020-2033
    • 6.4.15. Southeast Asia Active Wound Care Market Outlook, by End User, 2020-2033
    • 6.4.16. Rest of SAO Active Wound Care Market Outlook, by Product, 2020-2033
    • 6.4.17. Rest of SAO Active Wound Care Market Outlook, by Automation, 2020-2033
    • 6.4.18. Rest of SAO Active Wound Care Market Outlook, by End User, 2020-2033
  • 6.5. BPS Analysis/Market Attractiveness Analysis

7. Latin America Active Wound Care Market Outlook, 2020-2033

  • 7.1. Latin America Active Wound Care Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 7.1.1. Skin Substitutes
    • 7.1.2. Growth Factors
    • 7.1.3. Biomaterials
  • 7.2. Latin America Active Wound Care Market Outlook, by Automation, Value (US$ Bn), 2020-2033
    • 7.2.1. Chronic Wounds
    • 7.2.2. Acute Wounds
  • 7.3. Latin America Active Wound Care Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 7.3.1. Hospitals
    • 7.3.2. Home Healthcare
    • 7.3.3. Specialty Clinics
    • 7.3.4. Others
  • 7.4. Latin America Active Wound Care Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.4.1. Brazil Active Wound Care Market Outlook, by Product, 2020-2033
    • 7.4.2. Brazil Active Wound Care Market Outlook, by Automation, 2020-2033
    • 7.4.3. Brazil Active Wound Care Market Outlook, by End User, 2020-2033
    • 7.4.4. Mexico Active Wound Care Market Outlook, by Product, 2020-2033
    • 7.4.5. Mexico Active Wound Care Market Outlook, by Automation, 2020-2033
    • 7.4.6. Mexico Active Wound Care Market Outlook, by End User, 2020-2033
    • 7.4.7. Argentina Active Wound Care Market Outlook, by Product, 2020-2033
    • 7.4.8. Argentina Active Wound Care Market Outlook, by Automation, 2020-2033
    • 7.4.9. Argentina Active Wound Care Market Outlook, by End User, 2020-2033
    • 7.4.10. Rest of LATAM Active Wound Care Market Outlook, by Product, 2020-2033
    • 7.4.11. Rest of LATAM Active Wound Care Market Outlook, by Automation, 2020-2033
    • 7.4.12. Rest of LATAM Active Wound Care Market Outlook, by End User, 2020-2033
  • 7.5. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Active Wound Care Market Outlook, 2020-2033

  • 8.1. Middle East & Africa Active Wound Care Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 8.1.1. Skin Substitutes
    • 8.1.2. Growth Factors
    • 8.1.3. Biomaterials
  • 8.2. Middle East & Africa Active Wound Care Market Outlook, by Automation, Value (US$ Bn), 2020-2033
    • 8.2.1. Chronic Wounds
    • 8.2.2. Acute Wounds
  • 8.3. Middle East & Africa Active Wound Care Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 8.3.1. Hospitals
    • 8.3.2. Home Healthcare
    • 8.3.3. Specialty Clinics
    • 8.3.4. Others
  • 8.4. Middle East & Africa Active Wound Care Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.4.1. GCC Active Wound Care Market Outlook, by Product, 2020-2033
    • 8.4.2. GCC Active Wound Care Market Outlook, by Automation, 2020-2033
    • 8.4.3. GCC Active Wound Care Market Outlook, by End User, 2020-2033
    • 8.4.4. South Africa Active Wound Care Market Outlook, by Product, 2020-2033
    • 8.4.5. South Africa Active Wound Care Market Outlook, by Automation, 2020-2033
    • 8.4.6. South Africa Active Wound Care Market Outlook, by End User, 2020-2033
    • 8.4.7. Egypt Active Wound Care Market Outlook, by Product, 2020-2033
    • 8.4.8. Egypt Active Wound Care Market Outlook, by Automation, 2020-2033
    • 8.4.9. Egypt Active Wound Care Market Outlook, by End User, 2020-2033
    • 8.4.10. Nigeria Active Wound Care Market Outlook, by Product, 2020-2033
    • 8.4.11. Nigeria Active Wound Care Market Outlook, by Automation, 2020-2033
    • 8.4.12. Nigeria Active Wound Care Market Outlook, by End User, 2020-2033
    • 8.4.13. Rest of Middle East Active Wound Care Market Outlook, by Product, 2020-2033
    • 8.4.14. Rest of Middle East Active Wound Care Market Outlook, by Automation, 2020-2033
    • 8.4.15. Rest of Middle East Active Wound Care Market Outlook, by End User, 2020-2033
  • 8.5. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Smith & Nephew
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. MiMedx
    • 9.4.3. Tissue Regenix
    • 9.4.4. Organogenesis Inc.
    • 9.4.5. Acell Inc.
    • 9.4.6. Integra Life Sciences
    • 9.4.7. Solsys Medical
    • 9.4.8. Osiris Therapeutics Inc.
    • 9.4.9. Cytori Therapeutics Inc.
    • 9.4.10. Human BioSciences

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations